Philby, you have just got to be realistic. The stock should...

Philby, you have just got to be realistic. The stock should absolutely fly on clinical data and will probably fly well before data. Yes its taken way longer than anyone wanted but we have a "Worlds Best" Clinician (Killian) ensuring that it is a ground breaker. The management changed the trial so we got Efficacy in phase 1 as well as safety. The Efficacy won't be statistically relevant, but I believe and I reckon Management believes, relevant enough for Big Pharmas to write out some really big Cheques.

High profile Chairman, ADR, new recruits, it's just all short term noise.

I can smell this stock is starting to move on the upside. The big selling is done, the buying is building, the upside moves are measured (climbing the wall of worry),clinical trials are a few months away, deals are being negotiated, the MSC industry is consistently being validated (thank you MSB) and the regulators are giving manufactured MSC's the green light.